The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)

S. Wynne (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), S. Jones (London, United Kingdom), J. Walsh (London, United Kingdom), S. Kon (London, United Kingdom), J. Cairn (London, United Kingdom), M. Loebinger (London, United Kingdom), R. Wilson (London, United Kingdom), W. Man (London, United Kingdom), C. Nolan (London, United Kingdom)

Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Session: Hot topics in pulmonary rehabilitation
Session type: Poster Discussion
Number: 3407

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Wynne (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), S. Jones (London, United Kingdom), J. Walsh (London, United Kingdom), S. Kon (London, United Kingdom), J. Cairn (London, United Kingdom), M. Loebinger (London, United Kingdom), R. Wilson (London, United Kingdom), W. Man (London, United Kingdom), C. Nolan (London, United Kingdom). The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID). 3407

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between Hospital Anxiety and Depresion Scale (HADS) and clinical asthma control
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

Development and validation of the REspiratory Symptom in Preschool children Questionnaire (RESPQ)
Source: Eur Respir J 2005; 26: Suppl. 49, 478s
Year: 2005

Predictors of E-Cigarette Use: Smoking and Self-Identified Depression and/or Anxiety
Source: International Congress 2019 – From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use
Year: 2019




LATE-BREAKING ABSTRACT: Identity Consequence Fatigue Scale (ICFS) in COPD: Correlation with Severity, Risk of Hospitalization and Length of stay
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Health-related quality of life in COPD: why both disease-specific and generic measures should be used
Source: Eur Respir J 2001; 18: 69-76
Year: 2001



2 days at the sea-side! Effects on anxiety and depression scores, Health Locus of Control (HLOC) and Patient’s Global Impression of Change (PGIC) in COPD patients.
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018

Validity and reliability of the Stanford Brief Activity Survey (SBAS) in patients with COPD
Source: Annual Congress 2010 - Outcomes in chronic lung disease: assessing the value of interventions – physical activity, strength and exercise
Year: 2010

Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021



Development and validation of the Maugeri Sleep Quality and Distress Inventory (MaSQuDI–17)
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017


The validation of the Severe Asthma Questionnaire (SAQ).
Source: International Congress 2018 – Asthma management
Year: 2018



Fatigue in IPF measured by the Fatigue Assessment Scale during antifibrotic treatment
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018



Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) validated to Portuguese respiratory patients
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019


The cut-off values for Visual Analogue Scale (VAS) and for the Assessment Tool for Asthma (ATA) according the Control for Asthma and Allergic Rhinitis Test (CARAT)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Prevalence of Anxiety Disorders and Depression in Patients with Chronic Obstructive Pulmonary Disease and correlation with the clinical stage of the disease
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Post-COVID-19 Symptom Burden: What is Long-COVID and how should we manageit?
Source: Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19
Year: 2021



Implementation of the Brief Illness Perception Questionnaire (BIPQ) in pulmonary clinical practice – A multi-centre study
Source: Annual Congress 2010 - Medical education
Year: 2010


Responsiveness of the EQ-5D to Pulmonary Rehabilitation (PR)
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018

Development and validation of the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ)
Source: Eur Respir J, 54 (1) 1801375; 10.1183/13993003.01375-2018
Year: 2019



Depression in chronic obstructive pulmonary disease: Predictors and accuracy of the hospital anxiety and depression scale (HADS)
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014

Fatigue changes in IPF patients measured by the Fatigue Assessment Scale during antifibrotic treatment
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019